Is backscatter a function-independent method for assessment of treatment response to anti-fibrotic therapy in subclinical diabetic cardiomyopathy? Validation against T1 mapping and collagen biomarkers

in subclinical diabetic cardiomyopathy? Validation against T1 mapping and collagen biomarkers C. Jellis1, J. Wright2, J Sacre1, D. Kennedy3, L Jeffriess1, C. Jenkins1, J Fenwick3, J. Martin1, T. Marwick1,4 1. The University of Queensland, Brisbane, Australia; 2. Heart’s 1st, Greenslopes Private Hospital, Brisbane, Australia; 3. Queensland X-ray Brisbane, Australia; 4. Cleveland Clinic, Cleveland, OH.